ENTITY

FibroBiologics (FBLG US)

15
Analysis
Health Care • United States
FibroBiologics, Inc. operates as an early stage, cell therapy company. The Company develops food and drug administration trials related to fibroblast treatments for degenerative disc disease, multiple sclerosis, cancer, wound healing, and other diseases. FibroBiologics serves clients in the United States.
more
Company Event • 31 Oct 2026 04:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 23 Sep 2026 04:15 • Latest

Investor update

Company Event • 18 Sep 2026 00:00 • Upcoming
Add To Calendar

EGM 2026

Company Event • 17 Sep 2026 19:00 • Upcoming
Add To Calendar

Corporate presentation

Company Event • 09 Sep 2026 20:00 • Upcoming
Add To Calendar

Proxy filing

x